Together we will beat cancer


NICE meets to decide about kidney cancer drugs – we were there

35 experts, 7 administrators, 15 public observers… one very important decision. Last week, the National Institute of Health and Clinical…

Read More

NICE still reviewing their kidney cancer drug decision

Just a quick update on NICE’s ongoing appraisal of the use of four new drugs to treat metastatic kidney cancer….

Read More

NICE rejection of four kidney cancer drugs – our response

Thanks for all your comments on our blog about the recent decision by NICE to reject four drugs for advanced…

Read More

NICE decision on kidney cancer drugs – have your say

This morning, the UK’s drug guidance body, NICE, announced its preliminary decision on whether the NHS should use four new…

Read More